Jubilant Life Sciences said on Wednesday its unit has signed a $70-million contract to

RELATED ARTICLES Manufacturing sector to create 3-4 million jobs: Govt

manufacture an over-the-counter women's healthcare product for a U.S.-based company.

The product will be manufactured at its facility in Canada for a period of four years, it said in a statement.

The contract can be extended for another two years for a higher quantity, it said.

It did not name the U.S. firm or give details of the product.

"This contract is an outcome of our strategy to expand offerings across products and geographies. We are happy to extend services for an over-the-counter product with a leading customer in North America," Shyam Bhartia, chairman and managing director, Jubilant Life Sciences, said.

This is the second large deal for Jubilant in the last one month after it signed a $33 million manufacturing contract with a U.S. firm.

At 3:10 p.m., shares of Jubilant Life Sciences were trading down 0.77 percent at 213.40 rupees in a firm Mumbai market.